SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Cash Flow
Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q4 23), "Operating Cash Flow" came in at 146 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18 | 2.4 | 14 | 481 | 481 | 9,087 | 6,265 | -808 | 358 | -1,268 | 579 | 146 | |
| 0.8 | 1.6 | 0.3 | 1.3 | 1.3 | 17 | 69 | 78 | 208 | 152 | -73 | 61 | |
| 0.8 | 0.8 | 8.0 | 0.8 | 0.8 | – | -1.7 | -881 | -9.5 | -9.5 | -148 | – | |
| -1.7 | 3.0 | 16 | 65 | – | – | – | – | – | – | – | – | |
| -11 | 1.5 | -13 | 306 | 306 | 546 | -85 | -1,721 | -294 | -294 | 0.0 | 278 | |
| 3.0 | 33 | 33 | 58 | 58 | 444 | 307 | 289 | 21 | 269 | 15 | 53 | |
| 26 | -48 | -30 | -152 | -152 | -3,275 | 251 | -3,585 | -2,290 | – | -2,731 | -195 | |
| – | – | – | – | – | 23 | 1,876 | 19 | 170 | 263 | 145 | – | |
| 0.0 | 0.0 | – | – | – | – | -418 | -554 | -204 | – | -133 | – | |
| 5.9 | 18 | 14 | 536 | – | – | – | – | – | – | – | – | |
| 6.6 | 21 | 23 | 542 | 542 | -30 | -1,867 | 12 | -334 | -827 | -802 | -293 | |
| 13 | -24 | 9.2 | 896 | 896 | 6,698 | 4,763 | -4,753 | 97 | 3,236 | -163 | -371 | |
| -21 | -31 | -19 | 423 | 423 | 8,643 | 5,958 | -1,097 | 337 | -1,537 | 564 | 93 |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.